Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European thyroid association/European group on graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur Thyroid J 5:9–26

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bartalena L, Tanda ML (2022) Current concepts regarding Graves’ orbitopathy. J Intern Med 292:692–716

Article  PubMed  PubMed Central  CAS  Google Scholar 

Taylor PN, Zhang L, Lee RWJ et al (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol 16:104–116

Article  PubMed  CAS  Google Scholar 

Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285

Article  PubMed  CAS  Google Scholar 

Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association, Thyroid Group of Chinese Society of Endocrinology of Chinese Medical Association (2022) Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022). Chin J Ophthalmol 58:646–668

Google Scholar 

Wang Y, Zhang S, Zhang Y et al (2018) A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy. BMC Endocr Disord 18:13

Article  PubMed  PubMed Central  Google Scholar 

Civrny J, Karhanova M, Hubnerova P, Schovanek J, Herman M (2022) MRI in the assessment of thyroid-associated orbitopathy activity. Clin Radiol 77:925–934

Article  PubMed  CAS  Google Scholar 

Ma R, Geng Y, Gan L et al (2022) Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy. Endocrine 75:456–464

Article  PubMed  CAS  Google Scholar 

Kilicarslan R, Alkan A, Ilhan MM, Yetis H, Aralasmak A, Tasan E (2015) Graves’ ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Br J Radiol 88:20140677

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dodds NI, Atcha AW, Birchall D, Jackson A (2009) Use of high-resolution MRI of the optic nerve in Graves’ ophthalmopathy. Br J Radiol 82:541–544

Article  PubMed  CAS  Google Scholar 

Kahaly GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145:107–118

Article  PubMed  CAS  Google Scholar 

Ujhelyi B, Erdei A, Galuska L et al (2009) Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in graves’ ophthalmopathy. Thyroid 19:375–380

Article  PubMed  CAS  Google Scholar 

Jiang C, Deng Z, Huang J et al (2021) Monitoring and predicting treatment response of extraocular muscles in grave’s orbitopathy by (99m)Tc-DTPA SPECT/CT. Front Med (Lausanne) 8:791131

Article  PubMed  Google Scholar 

Liu D, Xu X, Wang S et al (2020) 99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves’ ophthalmopathy patients. Int Ophthalmol 40:553–561

Article  PubMed  Google Scholar 

Tang MT, Zeng XY, Li Y et al (2021) [The application of (99)tc(m)-DTPA orbital SPECT/CT in staging evaluation of thyroid associated ophthalmopathy]. Zhonghua Yan Ke Za Zhi 57:830–836

PubMed  CAS  Google Scholar 

Pasquali D, Notaro A, Bonavolonta G, Vassallo P, Bellastella A, Sinisi AA (2002) Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves’ disease. J Clin Endocrinol Metab 87:5125–5129

Article  PubMed  CAS  Google Scholar 

Cozma I, Zhang L, Uddin J, Lane C, Rees A, Ludgate M (2007) Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs. Am J Physiol Endocrinol Metab 293:E1630–1635

Article  PubMed  CAS  Google Scholar 

Pichler R, Sonnberger M, Dorninger C, Assar H, Stojakovic T (2011) Ga-68-DOTA-NOC PET/CT reveals active graves’ orbitopathy in a single extraorbital muscle. Clin Nucl Med 36:900–901

Article  Google Scholar 

Sun H, Jiang XF, Wang S et al (2007) (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active graves’ ophthalmopathy (GO). Endocrine 31:305–310

Article  PubMed  CAS  Google Scholar 

Zhao R, Wang J, Deng J, Yang W (2012) Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in graves’ ophthalmopathy. Am J Nucl Med Mol Imaging 2:242–247

PubMed  PubMed Central  CAS  Google Scholar 

Burggasser G, Hurtl I, Hauff W et al (2003) Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with graves’ disease. J Nucl Med 44:1547–1555

PubMed  Google Scholar 

Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V (2022) New PET radiotracers for the imaging of neuroendocrine neoplasms. Curr Treat Options Oncol 23:703–720

Article  PubMed  PubMed Central  Google Scholar 

Ambrosini V, Kunikowska J, Baudin E et al (2021) Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer 146:56–73

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shah MH, Goldner WS, Benson AB et al (2021) Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in Oncology. J Natl Compr Canc Netw 19:839–868

Article  PubMed  CAS  Google Scholar 

Fallahi B, Manafi-Farid R, Eftekhari M et al (2019) Diagnostic fficiency of (68)Ga-DOTATATE PET/CT as ompared to (99m)Tc-Octreotide SPECT/CT andonventional orphologic odalities in euroendocrine umors. Asia Ocean J Nucl Med Biol 7:129–140

PubMed  PubMed Central  Google Scholar 

Bartley GB, Gorman CA (1995) Diagnostic criteria for Graves’ ophthalmopathy. Am J Ophthalmol 119:792–795

Article  PubMed  CAS  Google Scholar 

Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185:G43–G67

Article  PubMed  CAS  Google Scholar 

Jiang CZ, Li XH, Deng HY et al (2018) Nontarget area and threshold selection in 99mTc-DTPA orbital SPECT/CT imaging inthyroid associated ophthalmopathy. J Cent South Univ Med Sci 43:869–874

Google Scholar 

Crisp M, Starkey KJ, Lane C, Ham J (2000) Adipogenesis in thyroid eye disease. Ophthalmol Vis Sci 41:3249–3255

CAS  Google Scholar 

Seboek D, Linscheid P, Zulewski H et al (2004) Somatostatin is expressed and secreted by human adipose tissue upon infection and inflammation. J Clin Endocrinol Metab 89:4833–4839

Article  PubMed  CAS  Google Scholar 

Weber M, Deuschl C, Bechrakis N et al (2021) 18F-FDG-PET/MRI in patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 259:3107–3117

Article  PubMed  PubMed Central  CAS  Google Scholar